000 | 01269 a2200349 4500 | ||
---|---|---|---|
005 | 20250518072536.0 | ||
264 | 0 | _c20210728 | |
008 | 202107s 0 0 eng d | ||
022 | _a1365-2125 | ||
024 | 7 |
_a10.1111/bcp.14185 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aWesterdijk, Kim | |
245 | 0 | 0 |
_aImatinib, sunitinib and pazopanib: From flat-fixed dosing towards a pharmacokinetically guided personalized dose. _h[electronic resource] |
260 |
_bBritish journal of clinical pharmacology _c02 2020 |
||
300 |
_a258-273 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
650 | 0 | 4 |
_aAntineoplastic Agents _xadverse effects |
650 | 0 | 4 | _aDrug Monitoring |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aImatinib Mesylate |
650 | 0 | 4 | _aIndazoles |
650 | 0 | 4 |
_aProtein Kinase Inhibitors _xadverse effects |
650 | 0 | 4 | _aPyrimidines |
650 | 0 | 4 | _aSulfonamides |
650 | 0 | 4 | _aSunitinib |
700 | 1 | _aDesar, Ingrid M E | |
700 | 1 | _aSteeghs, Neeltje | |
700 | 1 | _avan der Graaf, Winette T A | |
700 | 1 | _avan Erp, Nielka P | |
773 | 0 |
_tBritish journal of clinical pharmacology _gvol. 86 _gno. 2 _gp. 258-273 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/bcp.14185 _zAvailable from publisher's website |
999 |
_c30366747 _d30366747 |